Spok (NASDAQ:SPOK - Get Free Report) issued its quarterly earnings results on Wednesday. The Wireless communications provider reported $0.21 EPS for the quarter, Zacks reports. The company had revenue of $34.91 million for the quarter. Spok had a return on equity of 9.43% and a net margin of 11.27%. Spok updated its FY 2024 guidance to EPS.
Spok Trading Down 8.1 %
SPOK stock traded down $1.27 during trading hours on Thursday, hitting $14.45. 491,087 shares of the stock traded hands, compared to its average volume of 149,222. The stock has a 50-day simple moving average of $16.29 and a 200 day simple moving average of $15.93. Spok has a one year low of $10.46 and a one year high of $18.14. The company has a market cap of $292.61 million, a P/E ratio of 18.60 and a beta of 0.27.
Spok Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 29th. Investors of record on Friday, March 15th were paid a dividend of $0.313 per share. The ex-dividend date was Thursday, March 14th. This represents a $1.25 annualized dividend and a yield of 8.66%. This is a boost from Spok's previous quarterly dividend of $0.31. Spok's dividend payout ratio (DPR) is currently 162.34%.
Insider Activity at Spok
In related news, Director Todd J. Stein sold 25,927 shares of the firm's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $17.92, for a total transaction of $464,611.84. Following the completion of the transaction, the director now owns 696,637 shares of the company's stock, valued at $12,483,735.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.88% of the company's stock.
Spok Company Profile
(
Get Free Report)
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
Featured Articles
Before you consider Spok, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spok wasn't on the list.
While Spok currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
